Ido Kilemnik
Co-founder & CEO
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
Medi-Tate
Former names:
Treatment for Urethral and Prostate Diseases
Stealth Mode
by Olympus Corporation on Feb, 2021
Medi-Tate
Medi-Tate Overview
Medi-Tate develops new solutions for treating diseases of the urethra and prostate. Its solutions are designed to reduce associated symptoms and significantly improve patients' quality of life.
The Medi-Tate device offers patients relief from the symptoms of benign prostate hyperplasia (BPH). The device is placed in the prostatic urethra for five days. During this time, it pushes obstructive tissue to the side, reshaping the prostate to create a long-term therapeutic effect.
The device can be deployed in any clinical setting with standard rigid cystoscopy equipment. The deployment procedure is intuitive and does not require a postprocedural catheter. Once the device is deployed, the patient is free to return to normal activities immediately.
Medi-Tate's iTind system for the treatment of BPH is CE marked and available for sale in the European Union, Canada, Hong Kong, and Israel. In April 2020, the company received an FDA De Novo classification for its iTind system.
The Medi-Tate device offers patients relief from the symptoms of benign prostate hyperplasia (BPH). The device is placed in the prostatic urethra for five days. During this time, it pushes obstructive tissue to the side, reshaping the prostate to create a long-term therapeutic effect.
The device can be deployed in any clinical setting with standard rigid cystoscopy equipment. The deployment procedure is intuitive and does not require a postprocedural catheter. Once the device is deployed, the patient is free to return to normal activities immediately.
Medi-Tate's iTind system for the treatment of BPH is CE marked and available for sale in the European Union, Canada, Hong Kong, and Israel. In April 2020, the company received an FDA De Novo classification for its iTind system.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Medi-Tate Climate Tech relevance
null
No Data, yet.
Sorry, no content found under this section.
Jun 23, 2022
www.prnewswire.com
First BPH Treatment Procedures Performed in Canada with Minimally Invasive iTind Device
#Customers
May 18, 2022
www.prnewswire.com
Study Results Show Long-term Efficacy of iTind Procedure
#Customers
Sep 20, 2021
www.prnewswire.com
Olympus Selected To Exhibit iTind Device For BPH Treatment At Vizient Innovative Technology Exchange
#Partners #Customers
Feb 27, 2021
en.globes.co.il
Olympus buys Israeli co Medi-Tate for $300m
#Acquisition
Mar 6, 2020
tmgpulse.com
iTind for Benign Prostatic Hyperplasia Gets FDA Green Light - TMG Pulse
#Investment #Partners
Companies you might be interested in
Driven by Finder AI
-
Lyra MedicalLong-term Solution for Pelvic Floor Repair1-10 employees • Funding Stage: Mature
shared sectors
Also shared
Are these companies similar? -
Conair MedicalImplant-Based Solutions1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
Pulsetech MedicalNeuromodulation Platform Aiming to Halt Progression of Neurodegenerative Movement DisordersAre these companies similar? -
CATHETRIXCatheter Securement Device1-10 employees • Funding Stage: Mature
shared sectors
Also shared
Are these companies similar?
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
IK
LL
VM
Contact Team
Affiliated Organizations
(null)Web & social links
https://www.itind.com/
Locations
Israel
Offices Abroad
Photos & videos
(3)No Data, yet.
Sorry, no content found under this section.
Medi-Tate Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)Medi-Tate Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
M&A
EXIT
$250M
Feb 2021
Type
Acquisition
Was acquired by
Olympus Corporation
$250M
Private Equity Funding
B Round
$8M
Jul 2016
2
Investors
$8M
Non-Equity Funding
Mergers and Acquisitions
Medi-Tate Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
M&A
EXIT
$250M
Feb 2021
Type
Acquisition
Was acquired by
Olympus Corporation
$250M
B Round
$8M
Jul 2016
2
Investors
$8M
Medi-Tate News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Jun 23, 2022
www.prnewswire.com
First BPH Treatment Procedures Performed in Canada with Minimally Invasive iTind Device
#Customers
May 18, 2022
www.prnewswire.com
Study Results Show Long-term Efficacy of iTind Procedure
#Customers
Sep 20, 2021
www.prnewswire.com
Olympus Selected To Exhibit iTind Device For BPH Treatment At Vizient Innovative Technology Exchange
#Partners #Customers
Feb 27, 2021
en.globes.co.il
Olympus buys Israeli co Medi-Tate for $300m
#Acquisition
Mar 6, 2020
tmgpulse.com
iTind for Benign Prostatic Hyperplasia Gets FDA Green Light - TMG Pulse
#Investment #Partners
Related Content
Medi-Tate Team
No Data, yet.
Sorry, no content found under this section.
Employees Over Time
Companies you might be interested in
Driven by Finder AI
-
Lyra MedicalLong-term Solution for Pelvic Floor Repair1-10 employees • Funding Stage: Mature
shared sectors
Also shared
Are these companies similar? -
Conair MedicalImplant-Based Solutions1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
Pulsetech MedicalNeuromodulation Platform Aiming to Halt Progression of Neurodegenerative Movement DisordersAre these companies similar?
-
CATHETRIXCatheter Securement Device1-10 employees • Funding Stage: Mature
shared sectors
Also shared
Are these companies similar?
Medi-Tate Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,